Autonomix Medical, Inc. (AMIX) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US05330T3041

Price
1.37 USD
Market cap
2.80 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
-283.55 %
Return on assets (ROA)
-219.93 %

Autonomix Medical, Inc. financials

Fiscal year20252026
Revenue0.00 USD0.00 USD
Operating income-11.59 m USD-17.03 m USD
EBIT-11.59 m USD-17.03 m USD
Net income-11.41 m USD-16.72 m USD

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Autonomix Medical, Inc.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.